Kazia Therapeutics KZIA
NASDAQ KZIA
$8.29 +0.11 (+1.37%)
As of: Oct 22, 2026 · 11:43 AM EDT

Kazia Therapeutics (KZIA) Net Margin (2009 - 2013)

Updated

Kazia Therapeutics (KZIA) posted Net Margin of -49345.24% for the year ended Jun 30, 2025, down 48184.67 percentage points from -1160.57% a year earlier.

Analysis

Kazia Therapeutics (KZIA) Net Margin (2009 - 2013) Analysis & Trends

Since the year ended Jun 30, 2009, Kazia Therapeutics has reported Net Margin for 13 years.

  • Annual Net Margin shows a four-year change of -49289.78 percentage points (years ended Jun 2021 to Jun 2025).
  • The figure for the year ended Jun 30, 2025 stands as the lowest annual Net Margin in data going back to the year ended Jun 30, 2009.
  • Business Quant data shows KZIA's Net Margin at -1160.57% in the year ended Jun 30, 2024 and -55.46% in the year ended Jun 30, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,170.58 Bn 1,139.17 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 639.26 Bn 557.79 Bn 17.26 Bn 21.86%
3 AbbVie 501.86 Bn 474.97 Bn 12.70 Bn 21.27%
4 Merck 374.72 Bn 329.10 Bn 12.21 Bn -8.04%
5 Novartis Ag 302.72 Bn 266.71 Bn 11.24 Bn 22.65%
6 Astrazeneca 268.40 Bn 242.08 Bn 12.86 Bn 16.30%
7 Amgen 242.11 Bn 197.51 Bn 7.24 Bn 23.62%
8 Gilead Sciences 193.45 Bn 167.65 Bn 6.22 Bn -134.51%
9 Pfizer 172.31 Bn 118.96 Bn 10.94 Bn -1.65%
10 Kazia Therapeutics 611,079.52 -51.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 30, 2013 -123.39%
Dec 31, 2012 239.22%
Dec 31, 2011 1,187.05%
Dec 31, 2010 890.52%
Jun 30, 2010 -4,982.35%
Dec 31, 2009 -913.06%
API Access

Kazia Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=KZIA&period=max&api_key=YOUR_API_KEY